Guide · Updated November 2026

Fat Loss vs. Weight Loss on GLP-1s: Why Your Scale Is Lying to You

In the main GLP-1 trials, roughly a quarter to two-fifths of the weight people lost was lean mass (muscle plus organs, water and other non-fat tissue), not fat. In the STEP 1 semaglutide trial's DEXA substudy, lean mass made up roughly 40% of weight lost. In SURMOUNT-1's DEXA substudy, about 25% of weight lost on tirzepatide was lean mass. DEXA scans are one of the most accurate ways to track whether you are losing fat or lean tissue.

Six months into Mounjaro, I was down 38 pounds. My doctor was thrilled. My clothes were falling off. And I was quietly convinced I was also losing a significant amount of muscle, because I looked softer than I expected to for someone who had lost that much weight.

So I booked a DEXA scan. The results were not what I feared, but they were not what I hoped for either. They were complicated. And they made me realize that the number on my bathroom scale was only telling a fraction of the story.

The distinction between fat loss and weight loss on GLP-1 medications is one of the most misunderstood topics in the space. This article breaks down what actually happens to your body composition on these drugs, what the clinical trials show about muscle loss, how I track my own progress with DEXA, and why optimizing for the scale alone is the wrong goal.

What “Weight Loss” Actually Measures

Your scale measures gravity’s pull on your total mass. That includes fat, muscle, bone, water, glycogen stores, the food currently in your digestive tract, and everything else. When the number drops, any combination of those components could be responsible.

This matters because not all weight loss is equal. Losing a pound of fat is metabolically very different from losing a pound of muscle. Fat is stored energy. Muscle is metabolically active tissue that burns calories at rest, supports movement, and protects your joints and bones as you age.

When people talk about wanting to lose weight, they almost universally mean they want to lose fat while keeping muscle. The scale cannot tell you whether you achieved that.

Why GLP-1s Complicate This Further

GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) work primarily by suppressing appetite. You eat significantly less. A large caloric deficit is exactly what drives rapid weight loss on these drugs. The appetite suppression also comes with side effects that can make eating enough protein challenging, which matters for muscle preservation.

The problem is that rapid weight loss from any large caloric deficit, drug-induced or not, tends to come with meaningful lean mass loss alongside fat loss. Your body is not precise about what it burns when you’re in a steep deficit. It pulls from fat stores, yes. But it also pulls from muscle if the conditions are right.

The question for GLP-1 users is not whether you will lose some muscle. You probably will. The question is how much, how to minimize it, and whether the net body composition change is still favorable.

What the Clinical Trials Actually Found

The STEP 1 and SURMOUNT-1 trials included body composition measurements, so we have reasonably good data on this.

Semaglutide (STEP 1)

In the STEP 1 trial published in the New England Journal of Medicine in February 2021, participants on 2.4 mg semaglutide lost an average of 14.9% of body weight over 68 weeks, or 15.3 kg (about 33.7 pounds). What the headline numbers don’t tell you is where that weight came from.

In STEP 1’s DEXA substudy of 140 participants, total fat mass fell 19.3% and lean mass fell 9.7% on semaglutide. That works out to roughly 40% of the weight lost coming from lean tissue. Lean mass still rose as a share of total body mass, by 3.0 percentage points.

Tirzepatide (SURMOUNT-1)

SURMOUNT-1, published in NEJM in July 2022, also measured body composition. In its DEXA substudy of 160 participants, total fat mass fell 33.9% and lean mass fell 10.9% across the tirzepatide doses. About 75% of the weight lost was fat and 25% was lean mass, and the authors report the same split in the placebo group.

On paper that looks better than STEP 1, but these were separate trials with different people and methods. They were not a head-to-head comparison.

Here is how those numbers compare side by side:

Both drugs cause some lean mass loss. Neither is a free pass. A 2024 review in Diabetes, Obesity and Metabolism found wide variation across studies, with lean mass ranging from about 15% to 60% of weight lost. It also points out that lean mass is not the same as muscle, since it includes organs, bone and water.

For a deeper comparison of how these two drugs perform overall, see our Mounjaro dosage guide.

My DEXA Results: Six Months on Mounjaro

The numbers below are my own. One person’s results are not evidence for anyone else.

I got my first DEXA scan about three months after starting Mounjaro, then another at the six-month mark. I am going to share the actual numbers because vague descriptions are useless. For the full breakdown including regional body composition data, see my complete DEXA scan results after 6 months on Mounjaro.

Baseline (before Mounjaro):

• Total weight: 247 lbs
• Body fat: 34.2% (84.5 lbs fat mass)
• Lean mass: 158.7 lbs
• Bone mineral content: ~3.8 lbs

At 3 months (down 19 lbs, on 7.5mg):

• Total weight: 228 lbs
• Body fat: 31.1% (70.9 lbs fat mass)
• Lean mass: 153.4 lbs
• Change: Lost 13.6 lbs fat, lost 5.3 lbs lean mass

So at three months, about 28% of my weight loss was lean mass. Better than the trial averages, but I was also lifting weights three times a week and hitting roughly 160-180g of protein per day. Without that, I suspect the lean mass loss would have been worse.

At 6 months (down 38 lbs total, on 10mg):

• Total weight: 209 lbs
• Body fat: 27.8% (58.1 lbs fat mass)
• Lean mass: 147.4 lbs
• Change from baseline: Lost 26.4 lbs fat, lost 11.3 lbs lean mass

Over six months, about 30% of my total weight loss was lean mass. The other 70% was fat. My body fat percentage dropped from 34.2% to 27.8%, which is a significant shift in actual body composition even though I lost some muscle.

The scale said I lost 38 pounds. The DEXA said I lost 26 pounds of fat and 11 pounds of muscle. Those are very different stories.

Why This Matters More Than You Think

Losing 11 pounds of muscle over six months is not catastrophic, especially given the concurrent fat loss. But it is worth understanding the downstream consequences.

Metabolic rate. Muscle burns more calories at rest than fat does. Lose a significant amount of lean mass and your resting metabolic rate drops. This is part of why people who lose weight through severe caloric restriction often regain it. Their bodies now burn fewer calories at baseline.

Body composition rebound risk. If you stop a GLP-1 and your appetite returns to baseline, but your metabolic rate is now lower than it was before you started, you are in a worse position than when you began. The regain tends to come back as fat, not muscle, which worsens your body composition further.

Functional strength. This is the one people underestimate. At six months on Mounjaro, I was noticeably weaker in the gym. Not dramatically, but my bench press dropped about 15 lbs from my pre-drug numbers even though I was training consistently.

Long-term metabolic health. This is the goal behind the goal. Wegovy is FDA-approved to reduce the risk of major cardiovascular events in adults with heart disease and obesity or overweight, and these drugs improve blood sugar and other metabolic markers in trials. Keeping as much muscle as you can while losing fat supports that.

How to Shift the Equation Toward Fat Loss

You cannot completely prevent lean mass loss on a GLP-1-driven caloric deficit. You can work to shift the ratio. Here is what expert groups recommend, plus what I do.

Resistance Training

This is the most important lever you have. Resistance training signals to your body that muscle is worth preserving. Without that signal, a caloric deficit pulls from both fat and muscle indiscriminately.

A 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society lists “preserving muscle and bone mass through resistance training and appropriate diet” as a priority during GLP-1 treatment. If your goal is body composition rather than just scale weight, skipping strength training works against you.

I lift three days a week: upper/lower split, mostly compound movements. Not glamorous. My lean mass share over six months came in below the STEP 1 figure, and I credit the lifting, though one person’s result proves nothing.

For more on this topic, including specific protocols, see our guide on GLP-1s, exercise, and muscle.

Protein Intake

When calories drop, protein needs to stay adequate. The joint advisory flags nutrient deficiencies and muscle loss as risks of the lower calorie intake on GLP-1s. Ask your prescriber or a registered dietitian for a protein target that fits your kidneys, health history and size. On GLP-1s, where appetite suppression can make it hard to eat enough of anything, getting enough protein takes planning.

My approach: protein comes first at every meal. If I only have room for 400 calories at lunch, I make sure 150-180 of those calories are protein. Greek yogurt, cottage cheese, eggs, chicken, protein shakes when appetite is low. It is mechanical at this point.

Rate of Loss

Faster is not always better. The Mounjaro label has you start at 2.5 mg and move up in 2.5 mg steps after at least 4 weeks on each dose, and your prescriber can hold you at a dose longer. Don’t change your dose on your own. The label also carries a boxed warning about thyroid C-cell tumors, and warns about pancreatitis, gallbladder disease and kidney problems from dehydration, so report severe stomach pain or vomiting to your prescriber. If loss stalls completely, our Mounjaro plateau guide covers what to discuss with them.

I pushed my dose from 5mg to 7.5mg at month two and the weight dropped fast but so did my lean mass numbers. Going from 7.5mg to 10mg at month five, I was more deliberate about my protein intake and training, and the lean mass loss rate slowed.

How to Actually Track Body Composition

The scale is not going to tell you any of this. Here are the options, roughly ranked by accuracy.

I use DEXA every 3 months and a tape measure weekly. The DEXA gives me actual data. The tape measure gives me directional feedback between scans so I know if I am trending the right way. If cost is a concern, our cheapest GLP-1 options guide covers how to minimize what you spend on the medication itself so you have budget for tracking tools like DEXA.

Home bioelectrical impedance scales like the Withings Body+ are not accurate enough for precise tracking, but they can be useful for spotting trends if you use them consistently under the same conditions (same time of day, same hydration state). Do not compare single readings. Compare 4-week averages.

What Numbers to Track

Beyond the scale, these are the metrics worth monitoring on a GLP-1:

• Body fat percentage. The main outcome. Are you losing fat as a proportion of your total mass?
• Lean mass in pounds. Are you losing muscle at a concerning rate?
• Waist circumference. Strongly correlated with visceral fat, which is the metabolically dangerous kind. This often drops faster than total weight.
• Waist-to-hip ratio. Another proxy for visceral fat distribution.
• Progress photos every 4 weeks. Tedious but useful. Pair with DEXA to understand what body composition shifts actually look like visually.

The Scale Does Get Some Things Right

To be fair, scale weight is not useless. It is easy to measure, consistent, and a reasonable proxy for direction of travel. If you are losing 2 pounds a week for months, something real is happening.

The problem is using it as your only metric, or treating it as a precise measure of fat loss. A 2-pound gain after a high-sodium weekend is not fat gain. A week with no scale movement while you are in a caloric deficit might reflect water retention or glycogen loading from a harder training week.

Body weight also moves by a few pounds across a single day based on food, water, and digestive contents. Weighing yourself every morning and treating each reading as meaningful is a reliable way to make yourself miserable.

My approach: weigh daily, record it, and look at the 7-day rolling average. Individual days are noise. Trends over 3 to 4 weeks are signal.

A Note on GLP-1 Discontinuation and Body Composition

This is where body composition tracking becomes especially important, and it connects to a genuine concern about these medications.

Most people regain weight after stopping GLP-1s. In the STEP 1 extension, participants regained two-thirds of their prior weight loss within a year of stopping semaglutide and the lifestyle program, and most cardiometabolic improvements drifted back toward baseline. That study did not measure whether the regain was fat or muscle.

This is not a reason to avoid GLP-1s. Don’t stop or restart one without talking to your prescriber. But it is a reason to think carefully about long-term strategy, including whether you plan to stay on the medication indefinitely, and what your plan is for maintaining muscle through diet and training regardless.

If you are evaluating whether to start a GLP-1 and want to compare costs and providers, our provider directory has current pricing and what each service includes.

You can also check our insurance coverage guide if you are trying to figure out whether your plan will cover any of this, because the cost math changes significantly if you have coverage. Medicare beneficiaries should see our Medicare GLP-1 coverage guide for the latest on the $50/month program.

The Bottom Line

The fat loss vs. weight loss distinction on GLP-1s is not academic. It determines whether your body composition actually improves, whether your metabolism is in a better position after treatment, and whether the results you see are real or partly illusory.

Both tirzepatide and semaglutide cause some lean mass loss alongside fat loss. In their main trials, roughly 25% to 40% of weight lost was lean tissue, and other studies range wider. My own DEXA data landed at about 30% lean mass over six months, alongside resistance training and high protein intake.

If you are on a GLP-1 and only tracking the scale, you are missing the most important information. Consider a DEXA scan. Lift weights. Ask your care team for a protein target. The scale will keep moving either way. What matters is what you are actually losing.

Frequently Asked Questions

Do GLP-1 medications cause muscle loss?

Yes, to varying degrees. In the main trials, roughly 25% to 40% of weight lost on GLP-1s was lean mass rather than fat. Expert groups recommend resistance training and enough protein to help preserve muscle. The tirzepatide trial showed a lower lean share than the semaglutide trial, but they were not head-to-head.

Is fat loss vs. weight loss on GLP-1s something my doctor will track?

Probably not unless you ask. Most clinical monitoring focuses on scale weight, waist circumference, and metabolic labs. DEXA scans are rarely ordered as standard of care for GLP-1 patients. If body composition matters to you, you will likely need to seek out and pay for DEXA scans yourself. Prices and prescription rules vary by center, so call ahead.

Why does the scale sometimes not move even when I am losing fat?

Water retention, muscle glycogen, hormonal fluctuations, and digestive contents all affect the scale independently of fat loss. Starting a resistance training program often causes the body to retain water in muscles as they adapt, which can mask fat loss on the scale for weeks. This is why DEXA or tape measurements give better information than daily weigh-ins alone.

How much muscle loss is too much on a GLP-1?

There is no agreed threshold. If your body fat percentage is not improving even as the scale drops, that is a sign to talk with your prescriber about your training and diet. Older adults face higher risk of muscle loss, so raise it early. Regular DEXA scans every 3 to 6 months will catch this early.

Can you build muscle while on a GLP-1?

It is difficult to build muscle in a significant caloric deficit, which is the situation most GLP-1 users are in. The more realistic goal is minimizing lean mass loss rather than adding new muscle during active weight loss. Once you reach a stable weight and increase calories back toward maintenance, building muscle becomes more feasible, and your body composition at that point will reflect how well you protected lean mass during the loss phase.

Related

Guides:

• Cheapest GLP-1 Online · Insurance Coverage · Side Effects
• Mounjaro Dosage Guide · Oral vs Injectable · Exercise and Muscle
• DEXA Scan Results on Mounjaro · Mounjaro Plateau Guide · Medicare GLP-1 Coverage

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Compare: All Providers · Best GLP-1 Programs · All Guides

What we checked

This AI-assisted public-source desk check reviewed the STEP 1 and SURMOUNT-1 trial papers in NEJM, the SURMOUNT-1 body composition analysis, the STEP 1 extension study, a 2024 review of lean mass changes on GLP-1 drugs, the 2025 joint nutrition advisory, and the Mounjaro FDA label on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.